Meeting
2016 Gastrointestinal Cancers Symposium
Accuracy of clinical staging with EUS for early stage esophageal cancer: Are we denying patients beneficial neoadjuvant chemo-radiation?
Authors
Carrie Luu
Moffitt Cancer Center, Tampa, FL
Carrie Luu , Norbert Garcia-Henriquez , Jason Klapman , Cynthia L. Harris , Khaldoun Almhanna , Sarah E. Hoffe , Jose Mario Pimiento , Jacques Fontaine
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session A: Cancers of the Esophagus and Stomach
Track
Cancers of the Esophagus and Stomach
Sub Track
Multidisciplinary Treatment
Citation
J Clin Oncol 34, 2016 (suppl 4S; abstr 163)
DOI
10.1200/jco.2016.34.4_suppl.163
Abstract #
163
Poster Bd #
N11
Abstract Disclosures
Similar Posters
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Unveiling survival strategies: The impact of treatment modalities on patients with esophageal cancer and the role of racial disparities.
First Author: Dani Ran Castillo
Poster
2014 ASCO Annual Meeting
Preoperative chemoradiation versus preoperative chemotherapy alone for esophageal cancer: Higher response rates but equivalent survival.
First Author: Brendon Matthew Stiles
Poster
2012 Gastrointestinal Cancers Symposium
Retrospective analysis of neoadjuvant chemoradiotherapy for esophageal cancer: The Knight Cancer Institute experience.
First Author: Faisal A Siddiqui
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Disease-free survival (DFS) as a surrogate endpoint (SE) for overall survival (OS) in early-stage resected esophageal/gastroesophageal junction cancer (EC/GEJC): An analysis of SEER-Medicare data.
First Author: Jaffer A. Ajani